Related Experiment Video

Updated: May 31, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma

James A Bonner1, Eddy S Yang, Hoa Q Trummell

  • 1Department of Radiation Oncology, The University of Alabama at Birmingham, USA. jabonner@uabmc.edu

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|June 28, 2011
PubMed
Abstract

Insights

Depleting signal transducer and activator of transcription-3 (STAT-3) enhances cetuximab

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Epidermal growth factor receptor (EGFr) inhibition with cetuximab reduces cancer cell proliferation and survival.
  • The signal transducer and activator of transcription-3 (STAT-3) pathway is implicated in EGFr signaling.
  • STAT-3's role in cetuximab's efficacy in head and neck cancers requires further investigation.

Purpose of the Study:

  • To investigate if STAT-3 depletion augments cetuximab-induced anti-cancer effects in human head and neck squamous carcinoma cells.
  • To assess the impact of STAT-3 knockdown on radiosensitivity, proliferation, apoptosis, and DNA damage in response to cetuximab.

Main Methods:

  • Human head and neck squamous carcinoma cells (UM-SCC-5) were transfected with short hairpin RNA (shRNA) targeting STAT-3.
  • Control cells were transfected with a mutated shRNA.
  • Radiosensitivity, proliferation, apoptosis, and DNA damage were assessed using colony formation assays, cell counts, annexin V-FITC assay, and alkaline comet assay, respectively.

Main Results:

  • STAT-3 knockdown cells exhibited enhanced radiosensitivity and increased apoptosis compared to control cells.
  • Cetuximab treatment led to decreased proliferation in STAT-3 knockdown cells.
  • STAT-3 knockdown cells showed increased sensitivity to cetuximab, correlating with elevated apoptosis and DNA damage.

Conclusions:

  • STAT-3 depletion significantly enhances the anti-proliferative effects and cytotoxicity of cetuximab in head and neck cancer cells.
  • These findings suggest that STAT-3 plays a crucial role in mediating cellular apoptosis and DNA damage, influencing cetuximab's efficacy.
  • Targeting STAT-3 may represent a promising strategy to augment cetuximab-based therapies for head and neck cancers.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...